quadrivalent VesiculoVax-vectored vaccine (Profectus BioSciences)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namequadrivalent VesiculoVax-vectored vaccine (Profectus BioSciences)

Drug Alias Namemulti-component VesiculoVax-vectored vaccine(Profectus BioSciences)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsMarburg Virus DiseaseHemorrhagic Fever, EbolaLassa Fever

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsMarburg Virus DiseaseHemorrhagic Fever, EbolaLassa Fever

Other Information

ATC CodeN/A